Company / Operating Income per Share
LENZ Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.31
FY2025
5-year range
-$36.97 / -$1.93
FY2021-FY2025
Trend
-20.3%
vs FY2024
Sector context
#144 of 201
Health Care
What the data says
At $-3.31, LENZ Therapeutics, Inc.'s operating income per share ranks #144 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 6 years, ranging from $-36.97 in FY2023 to $-1.93 in FY2022.
Based on SEC 10-K filings.
-3.31 in FY2025.
Improved from $-36.97 to $-3.31 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#144 of 201 in Health CareTop 72% of 201This company -$3.31 Sector average -$28.56
▼
+88.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 20.3% year-over-year.
- Ranks #144 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.31 | -20.3% |
| FY2024 | -$2.75 | +92.6% |
| FY2023 | -$36.97 | -1820.4% |
| FY2022 | -$1.93 | +7.9% |
| FY2021 | -$2.09 | +64.6% |
| FY2020 | -$5.91 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026